BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $29
RXO Analyst Ratings
Goldman Sachs Maintains RXO Inc(RXO.US) With Hold Rating, Raises Target Price to $29
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $12
RXO Is Maintained at Negative by Susquehanna
Susquehanna Maintains Negative on RXO, Lowers Price Target to $12
RXO Price Target Maintained With a $33.00/Share by Citigroup
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $12 to $33
RXO Analyst Ratings
Wells Fargo Initiates RXO Inc(RXO.US) With Hold Rating, Announces Target Price $31
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Maintains Target Price $32
A Quick Look at Today's Ratings for RXO Inc(RXO.US), With a Forecast Between $25 to $31
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $30
Benchmark Co. Maintains RXO Inc(RXO.US) With Hold Rating
BofA Securities Maintains RXO Inc(RXO.US) With Hold Rating, Maintains Target Price $30
RXO Analyst Ratings
Wolfe Research Maintains RXO Inc(RXO.US) With Sell Rating, Raises Target Price to $23
Citigroup Initiates RXO at Buy With $33 Price Target
SIG Maintains RXO Inc(RXO.US) With Sell Rating, Cuts Target Price to $16
RXO Is Maintained at Negative by Susquehanna
No Data
No Data